Metformin: a potential drug to treat hyperpigmentation disorders
- PMID: 25219649
- DOI: 10.1038/jid.2014.245
Metformin: a potential drug to treat hyperpigmentation disorders
Abstract
Hyperpigmentation disorders are generally difficult to treat because of the limited availability of effective therapeutics with minimal side effects. In this issue, Lehraiki et al. report that metformin, an antidiabetic drug, inhibited melanogenesis, in vitro and in vivo, and they suggest that metformin may be used to treat hyperpigmentation disorders. This commentary reviews the molecular mechanisms through which metformin inhibits melanogenesis and examines metformin as a potential drug to treat hyperpigmentation.
Comment on
-
Inhibition of melanogenesis by the antidiabetic metformin.J Invest Dermatol. 2014 Oct;134(10):2589-2597. doi: 10.1038/jid.2014.202. Epub 2014 Apr 22. J Invest Dermatol. 2014. PMID: 24756109
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
